Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H, Izumi N, Yamasaki T, Nojiri S, Hino K, et al. Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. Gut. 2019. 69. 8. 1492-1501
Ryu Sasaki, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Masaaki Hidaka, Susumu Eguchi, Satoshi Matsuo, Kazuaki Tajima, Toshihisa Matsuzaki, et al. Response to Lenvatinib Is Associated with Optimal RelativeDose Intensity in Hepatocellular Carcinoma: Experience in Clinical Settings. Cancers. 2019. 11. 11
Yuko Akazawa, Ryoma Nakashima, Katsuya Matsuda, Koji Okamaoto, Ran Hirano, Hiroko Kawasaki, Satoshi Miuma, Hisamitsu Miyaaki, Harmeet Malhi, Seigo Abiru, et al. Detection of DNA damage response in nonalcoholic fatty liver disease via p53-binding protein 1 nuclear expression. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2019. 32. 7. 997-1007